Company Search:
Advanced Search
Sponsored Links
Hybio Pharmaceutical Co Ltd Company Snapshot
Hybio Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hybio Pharmaceutical Co Ltd with three other companies in this sector in China: Jinhe Biotechnology Co Ltd (2017 sales of 1.46 billion Chinese Renmimbi [US$230.05 million] of which 67% was Medical Feeds Additives), Beijing Science Sun Pharmaceutical Co Ltd (749.99 million Chinese Renmimbi [US$118.39 million] of which 100% was Phamaceutical Manufacturing Industry), and Zhejiang Jolly Pharmaceutical Co Ltd (793.91 million Chinese Renmimbi [US$125.32 million] of which 75% was Medicinal).

Sales Analysis. Hybio Pharmaceutical Co Ltd reported sales of 1.25 billion Chinese Renmimbi (US$196.72 million) for the year ending December of 2017. This represents an increase of 45.8% versus 2016, when the company's sales were 855.05 million Chinese Renmimbi. Sales at Hybio Pharmaceutical Co Ltd have increased during each of the previous five years (and since 2012, sales have increased a total of 451%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Hybio Pharmaceutical Co Ltd
  Stock Performance Chart for Hybio Pharmaceutical Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): 15.15
(Figures in Chinese Renmimbi)
1 Week -1.7%   13 Weeks 5.5%  
4 Weeks -7.2%   52 Weeks -12.4%  
Hybio Pharmaceutical Co Ltd Key Data:
  Ticker: 300199 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 1,246,233,504
(Year Ending Jan 2018).
Employees: 927
  Currency: Chinese Renmimbi Market Cap: 14,160,591,981
  Fiscal Yr Ends: December Shares Outstanding: 934,692,540
  Share Type: Class A Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.